Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis

American Journal of Gastroenterology

Volumn 96, Issue 5, 2001, Pages 1522-1528

  Levy, Aaron M ^a   Yamazaki, Kiyoshi ^a   Van Keulen, Virginia P ^a   Burgart, Lawrence J ^a   Sandborn, William J ^a   Phillips, Sidney F ^a   Kephart, Gail M ^a   Gleich, Gerald J ^a   Leiferman, Kristin M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL INFILTRATION; CLINICAL ARTICLE; COLLAGENOUS COLITIS; COLON; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CYTOTOXICITY; DEGRANULATION; EOSINOPHILIA; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0035006769     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02313-9     Document Type: Article

References (49)

1. Gleich G.J., Glitz D.G., Abu-Ghazaleh R.I. Eosinophil granule proteins Structure and function . Gleich G., Kay A. Eosinophils in allergy and inflammation. 1994;1-20 Marcel Dekker, New York.
2. Gleich G.J., Kita H., Adolphson C.R. Eosinophils. Frank M.M., Austen K.F., Claman H.N., Unanue E.R. Samter's immunologic diseases. vol 1:1995;205-245 Little, Brown, Boston.
3. Yamazaki K., Nakadate I., Suzuki K., et al. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol. 91:1996;516-522.
4. Yamazaki K., Suzuki K., Nakamura A., et al. Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology. 30:1999;71-78.
5. Gleich G.J., Frigas E., Loegering D.A., et al. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 123:1979;2925-2927.
6. Venge P., Dahl R., Fredens K., et al. Epithelial injury by human eosinophils. Am Rev Respir Dis. 138:1988;S54-S57.
7. Kato M., Kephart G.M., Talley N.J., et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Record. 252:1998;418-425.
8. Walsh R.E., Gaginella T.S. The eosinophil in inflammatory bowel disease. Scand J Gastroenterol. 26:1991;1217-1224.
9. Dvorak A.M. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo Cytotoxic potential in Crohn's disease . J Immunol. 125:1980;460-462.
10. Berstad A., Børkje B., Riedel B., et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepato-Gastroenterology. 40:1993;276-278.
11. Makiyama K., Kanzaki S., Yamasaki K., et al. Activation of eosinophils in the pathophysiology of ulcerative colitis. J Gastroenterol. 30:1995;64-69.
12. Dubucquoi S., Janin A., Klein O., et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut. 37:1995;242-246.
13. Levy A.M., Kita H. The eosinophil in gut inflammation Effector or director? Gastroenterology. 110:1996;952-954. (editorial).
14. Levy A.M., Gleich G.J., Sandborn W.J., et al. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc. 72:1997;117-123.
15. Raab Y., Fredens K., Gerdin B., et al. Eosinophil activation in ulcerative colitis Studies on mucosal release and localization of eosinophil granule constituents . Dig Dis Sci. 43:1998;1061-1070.
16. Talley N.J., Kephart G.M., McGovern T.W., et al. Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease. Gastroenterology. 103:1992;137-145.
17. Colombel J.F., Torpier G., Janin A., et al. Activated eosinophils in adult coeliac disease Evidence for a local release of major basic protein . Gut. 33:1992;1190-1194.
18. Zeroogian J.M., Chopra S. Collagenous colitis and lymphocytic colitis. Ann Rev Med. 45:1994;105-118.
19. Bogomoletz W.V. Collagenous, microscopic and lymphocytic colitis. An evolving concept. Virchows Archiv. 424:1994;573-579.
20. Bohr J. A review of collagenous colitis. Scand J Gastroenterol. 33:1998;2-9.
21. Tremaine W.J. Collagenous colitis and lymphocytic colitis Subject review and therapeutic alternatives . J Clin Gastroenterol. 30:2000;245-249.
22. Giardiello F.M., Bayless T.M., Jessurun J., et al. Collagenous colitis Physiologic and histopathologic studies in seven patients . Ann Intern Med. 106:1987;46-49.
23. Lazenby A.J., Yardley J.H., Giardiello F.M., et al. Lymphocytic ("microscopic") colitis. A comparative histopathologic study with particular reference to collagenous colitis. Human Pathol. 20:1989;18-28.
24. Geboes K. Collagenous and microscopic colitis Clinical importance . Netherlands J Med. 45:1994;47-51.
25. Jawhari A., Talbot I.C. Microscopic, lymphocytic and collagenous colitis. Histopathology. 29:1996;101-110.
26. Goff J.S., Barnett J.L., Pelke T., et al. Collagenous colitis Histopathology and clinical course . Am J Gastroenterol. 92:1997;57-60.
27. Filley W.V., Holley K.E., Kephart G.M., Gleich G.J. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet. 2:1982;11-16.
28. Peters M.S., Schroeter A.L., Kephart G.M., Gleich G.J. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol. 81:1983;39-43.
29. Johnston N.W., Bienenstock J. Abolition of non-specific fluorescent staining of eosinophils. J Immunol Methods. 4:1974;189-194.
30. Krenik K.D., Kephart G.M., Offord K.P., et al. Comparison of antifading agents used in immunofluorescence. J Immunol Method. 117:1989;91-97.
31. Bischoff S.C., Wedemeyer J., Herrmann A., et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology. 28:1996;1-13.
32. Lefort J., Nahori M.A., Ruffie C., et al. In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs. J Clin Invest. 97:1996;1117-1121.
33. Evans C.M., Fryer A.D., Jacoby D.B., et al. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest. 100:1997;2254-2262.
34. Jahnsen F.L., Brandtzaeg P., Halstensen T.S. Monoclonal antibody EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils. J Immunol Method. 175:1994;23-36.
35. Nakajima H., Loegering D.A., Kita H., et al. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins. J Leukoc Biol. 66:1999;447-454.
36. Metwali A., Blum A.M., Ferraris L., et al. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol. 52:1994;69-78.
37. Pincus S.H., Ramesh K.S., Wyler D.J. Eosinophils stimulate fibroblast DNA synthesis. Blood. 70:1987;572-574.
38. Birkland T.P., Cheavens M.D., Pincus S.H. Human eosinophils stimulate DNA synthesis and matrix production in dermal fibroblasts. Arch Dermatol Res. 286:1994;312-318.
39. Rochester C.L., Ackerman S.J., Zheng T., Elias J.A. Eosinophil-fibroblast interactions. Granule major basic protein interacts with IL-1 and transforming growth factor-β in the stimulation of lung fibroblast IL-6-type cytokine production. J Immunol. 156:1996;4449-4456.
40. Noguchi H., Kephart G.M., Colby T.V., Gleich G.J. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol. 140:1992;521-528.
41. Rask-Madsen J., Grove O., Hansen M.G., et al. Colonic transport of water and electrolytes in a patient with secretory diarrhea due to collagenous colitis. Dig Dis Sci. 28:1983;1141-1146.
42. Minnicozzi M., Durán W.N., Gleich G.J., et al. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol. 153:1994;2664-2670.
43. Jacoby D.B., Ueki I.F., Widdicombe J.H., et al. Effect of human eosinophil major basic protein on ion transport in dog tracheal epithelium. Am Rev Respir Dis. 137:1988;13-16.
44. Anthony A., Dhillon A.P., Nygard G., et al. Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther. 7:1993;29-39.
45. Schwab D., Raithel M., Ell C., et al. Patchy distribution pattern of eosinophil cationic protein (ECP) and tryptase in patients with collagenous colitis. Gastroenterology. 110:1996;A358. (abstract).
46. Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med. 2:1996;449-456.
47. Matthews A.N., Friend D.S., Zimmermann N., et al. Eotaxin is required for the baseline level of tissue eosinophils. Proc Natl Acad Sci USA. 95:1998;6273-6278.
48. Desreumaux P., Janin A., Colombel J.F., et al. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med. 175:1992;293-296.
49. Hankard G.F., Brousse N., Cezard J.P., et al. In situ interleukin 5 gene expression in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr. 24:1997;568-572.